Chemed Corporation
CHENYSEHealthcare● Active
$438.84
$-2.75(-0.62%)
Market Cap$5.8B
P/E Ratio—
52W High$565.66
52W Low$365.21
Chemed Corporation (CHE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CHE · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 23, 2026EPS Actual
$5.65
Est. $5.30 · +6.6%
Revenue
$0.66B
Est. $0.65B · +1.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 23, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
CHE reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $5.62 | — | — | — | $0.67B | — |
| ▲ Q2 FY2026 | Apr 23, 2026 | $5.30 | $5.65 | +6.6% | $0.66B | $0.65B | +1.2% |
| ▼ Q1 FY2026 | Feb 25, 2026 | $7.02 | $6.42 | -8.6% | $0.64B | $0.66B | -3.0% |
| ▼ Q4 FY2025 | Oct 28, 2025 | $5.39 | $5.27 | -2.2% | $0.62B | $0.66B | -5.2% |
| ▼ Q3 FY2025 | Jul 29, 2025 | $4.78 | $4.27 | -10.7% | $0.62B | $0.63B | -2.0% |
| ▲ Q2 FY2025 | Apr 23, 2025 | $5.55 | $5.63 | +1.4% | $0.65B | $0.64B | +0.8% |
| — Q1 FY2025 | Feb 26, 2025 | $6.78 | $6.83 | +0.7% | $0.64B | $0.64B | +0.6% |
| ▼ Q4 FY2024 | Oct 29, 2024 | $5.76 | $5.64 | -2.1% | $0.61B | $0.64B | -4.7% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$5.62
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 23, 2026Beat
EPS Actual
$5.65
EPS Est.
$5.30
EPS Surpr.
+6.6%
Revenue
$0.66B
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
$6.42
EPS Est.
$7.02
EPS Surpr.
-8.6%
Revenue
$0.64B
Q4 FY2025
Oct 28, 2025Miss
EPS Actual
$5.27
EPS Est.
$5.39
EPS Surpr.
-2.2%
Revenue
$0.62B
Q3 FY2025
Jul 29, 2025Miss
EPS Actual
$4.27
EPS Est.
$4.78
EPS Surpr.
-10.7%
Revenue
$0.62B
Q2 FY2025
Apr 23, 2025Beat
EPS Actual
$5.63
EPS Est.
$5.55
EPS Surpr.
+1.4%
Revenue
$0.65B
Q1 FY2025
Feb 26, 2025
EPS Actual
$6.83
EPS Est.
$6.78
EPS Surpr.
+0.7%
Revenue
$0.64B
Q4 FY2024
Oct 29, 2024Miss
EPS Actual
$5.64
EPS Est.
$5.76
EPS Surpr.
-2.1%
Revenue
$0.61B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $7.71 | $7.76 | $7.80 | 1 |
| Q3 FY2027 | $6.61 | $6.65 | $6.69 | 1 |
| Q2 FY2027 | $6.29 | $6.33 | $6.36 | 1 |
| Q1 FY2027 | $6.15 | $6.20 | $6.23 | 1 |
| Q4 FY2026 | $7.01 | $7.05 | $7.09 | 1 |
| Q3 FY2026 | $5.98 | $6.02 | $6.06 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.7B | $0.7B | $0.7B | 1 |
| Q3 FY2027 | $0.7B | $0.7B | $0.7B | 1 |
| Q2 FY2027 | $0.7B | $0.7B | $0.7B | 1 |
| Q1 FY2027 | $0.7B | $0.7B | $0.7B | 1 |
| Q4 FY2026 | $0.7B | $0.7B | $0.7B | 1 |
| Q3 FY2026 | $0.7B | $0.7B | $0.7B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 23, 2026 | +6.6% | $373.15 | $382.97 | +2.63% |
| ▼ Q1 FY2026 | Feb 25, 2026 | -8.6% | $468.32 | $466.60 | -0.37% |
| ▼ Q4 FY2025 | Oct 28, 2025 | -2.2% | $436.78 | $438.94 | +0.49% |
| ▼ Q3 FY2025 | Jul 29, 2025 | -10.7% | $466.08 | $464.69 | -0.30% |
| ▲ Q2 FY2025 | Apr 23, 2025 | +1.4% | $579.50 | $585.46 | +1.03% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +0.7% | $550.70 | $545.79 | -0.89% |
| ▼ Q4 FY2024 | Oct 29, 2024 | -2.1% | $608.85 | $609.80 | +0.16% |
| ▼ Q3 FY2024 | Jul 24, 2024 | -2.1% | $541.31 | $547.48 | +1.14% |
Q2 FY2026+2.63%
Report Date
Apr 23, 2026
EPS Beat/Miss
+6.6%
Price Before
$373.15
Price After
$382.97
Q1 FY2026-0.37%
Report Date
Feb 25, 2026
EPS Beat/Miss
-8.6%
Price Before
$468.32
Price After
$466.60
Q4 FY2025+0.49%
Report Date
Oct 28, 2025
EPS Beat/Miss
-2.2%
Price Before
$436.78
Price After
$438.94
Q3 FY2025-0.30%
Report Date
Jul 29, 2025
EPS Beat/Miss
-10.7%
Price Before
$466.08
Price After
$464.69
Q2 FY2025+1.03%
Report Date
Apr 23, 2025
EPS Beat/Miss
+1.4%
Price Before
$579.50
Price After
$585.46
Q1 FY2025-0.89%
Report Date
Feb 26, 2025
EPS Beat/Miss
+0.7%
Price Before
$550.70
Price After
$545.79
Q4 FY2024+0.16%
Report Date
Oct 29, 2024
EPS Beat/Miss
-2.1%
Price Before
$608.85
Price After
$609.80
Q3 FY2024+1.14%
Report Date
Jul 24, 2024
EPS Beat/Miss
-2.1%
Price Before
$541.31
Price After
$547.48
Avg Beat Reaction+0.92%
Avg Miss Reaction+0.22%
Beat Rate3 / 8 quarters
Largest Move+2.63% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CHE ends December
Chemed Corporation (CHE) most recently reported earnings on April 23, 2026 for Q2 FY2026, posting EPS of $5.65 — beating the analyst consensus of $5.30 by +6.6%. The next CHE earnings date is expected around September 1, 2026.
Each quarter, investors track CHE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CHE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CHE earnings · 5 questionsChemed Corporation's next earnings report is expected around September 1, 2026. CHE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHE historically reports after market close (AMC).
CHE earnings datewhen is CHE earningsCHE next earnings datewhen does CHE report earningsCHE earnings calendar
▸ Source: FMP · Chemed Corporation SEC filings · US GAAP · Chemed Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026